Target intelligence / Profile preview

Pro-inflammatory CD8+ T cells (Pro-inflammatory CTLs)

Target
Pro-inflammatory CTLs
Molecular classification
T cell, Cytotoxic T lymphocyte, Immune cell
01

Overview

Pro-inflammatory CD8+ T cells are a subset of cytotoxic T lymphocytes (CTLs) that, beyond their classical role in directly killing infected or malignant cells, also secrete pro-inflammatory cytokines and contribute to inflammatory processes in various diseases. These cells express the CD8 co-receptor and recognize antigens presented by MHC class I molecules on target cells. They directly kill virus-infected, cancerous, or otherwise abnormal host cells via release of perforin and granzymes and secrete pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ), which amplify local immune responses and inflammation. They can promote tissue damage in chronic inflammatory conditions by inducing apoptosis of non-infected host cells. Targeting the activity or abundance of pro-inflammatory CD8+ T-cells is being explored therapeutically for conditions where they drive pathology—such as cardiovascular disease or autoimmune disorders.

Other names
Proinflammatory CD8+ T cellsPro-inflammatory cytotoxic T lymphocytesActivated CD8+ T cellsEffector CD8+ T cells
02

Mechanism of action

Modulation of cytokine production; Inhibition of T cell activation; Induction of apoptosis

03

Biological functions

CytotoxicityImmune responseInflammationCytokine productionCell killing
04

Disease associations

AtherosclerosisAutoimmunityInflammatory diseasesType 1 DiabetesArthritis
05

Safety considerations

ImmunosuppressionIncreased risk of infectionOff-target effects on other immune cells
06

Biomarkers

IFN-γ levelsTNF-α levelsGZMB expressionCD8+ T cell count

Beyond the preview

Go deeper on Pro-inflammatory CD8+ T cells (Pro-inflammatory CTLs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro-inflammatory CD8+ T cells (Pro-inflammatory CTLs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call